BioScience Health Innovations, Inc.
BHIC
$6.40
$2.1048.84%
OTC PK
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 39.01% | -35.62% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 39.01% | -35.62% | |||
| Cost of Revenue | 131.05% | -36.57% | |||
| Gross Profit | -18.09% | -35.02% | |||
| SG&A Expenses | 3.04% | 14.62% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 51.68% | -12.28% | |||
| Operating Income | -1,680.68% | -101.92% | |||
| Income Before Tax | -1,680.68% | -101.92% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -2,554.55% | -101.92% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -2,554.55% | -101.92% | |||
| EBIT | -1,680.68% | -101.92% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -2,562.50% | -101.92% | |||
| Normalized Basic EPS | -1,680.00% | -101.92% | |||
| EPS Diluted | -2,562.50% | -102.00% | |||
| Normalized Diluted EPS | -1,680.00% | -101.94% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | -0.95% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||